PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2017

Effect of a new formulation of micronized and ultramicronized N-palmitoylethanolamine in a tibia fracture mouse model of complex regional pain syndrome.

Mouse / Fracture

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 28594885 ↗2017Reported benefit

Effect of a new formulation of micronized and ultramicronized N-palmitoylethanolamine in a tibia fracture mouse model of complex regional pain syndrome.

MouseFractureTibiaCD1Malen = n = 10 per group across 4 groupsOral300 mg/kg micronized PEA plus 600 mg/kg ultramicronized PEA…First dose 1 hour after fracture surgery

Model: Closed distal tibia fracture of the right hindlimb with casting for 28 days, a model of complex regional pain syndrome type I

Oral PEA-MPS started 1 h after tibia fracture and continued for 28 days reduced mechanical and thermal nociception and subjective pain, and improved callus formation, bone density and fracture healing. It lowered mast cell density, NGF, TNF-alpha, IL-1beta, nitrotyrosine, PAR and Bax while raising…

Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.95. Machine-extracted fields require source verification.